{"pmid":32353898,"title":"Histopathology and genetic susceptibility in COVID-19 pneumonia.","text":["Histopathology and genetic susceptibility in COVID-19 pneumonia.","The clinical features of COVID-19 range from a mild illness to patients with a very severe illness with acute hypoxemic respiratory failure requiring ventilation and Intensive Care Unit admission. Risk factors for a fatal disease include older age, respiratory disease, diabetes mellitus, obesity and hypertension. Little is known about the mechanisms behind observed episodes of sudden deterioration or the infrequent idiosyncratic clinical demise in otherwise healthy and young subjects. As in other diseases, the answer to some of these questions may in time be provided by genotyping as well careful clinical, serological, radiological and histopathological phenotyping, which enable mechanistic insights into the differences in pathogenesis and underlying immunological and tissue regenerative response patterns. We will aim to provide a brief overview of the existing evidence for such differences in host response and outcome, and generate hypotheses for divergent patterns and avenues for future research, by highlighting similarities and differences in histopathological appearance between COVID19 and influenza as well as previous coronavirus outbreaks, and by discussing predisposition through genetics and underlying disease.","Eur J Clin Invest","von der Thusen, Jan","van der Eerden, Menno","32353898"],"abstract":["The clinical features of COVID-19 range from a mild illness to patients with a very severe illness with acute hypoxemic respiratory failure requiring ventilation and Intensive Care Unit admission. Risk factors for a fatal disease include older age, respiratory disease, diabetes mellitus, obesity and hypertension. Little is known about the mechanisms behind observed episodes of sudden deterioration or the infrequent idiosyncratic clinical demise in otherwise healthy and young subjects. As in other diseases, the answer to some of these questions may in time be provided by genotyping as well careful clinical, serological, radiological and histopathological phenotyping, which enable mechanistic insights into the differences in pathogenesis and underlying immunological and tissue regenerative response patterns. We will aim to provide a brief overview of the existing evidence for such differences in host response and outcome, and generate hypotheses for divergent patterns and avenues for future research, by highlighting similarities and differences in histopathological appearance between COVID19 and influenza as well as previous coronavirus outbreaks, and by discussing predisposition through genetics and underlying disease."],"journal":"Eur J Clin Invest","authors":["von der Thusen, Jan","van der Eerden, Menno"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353898","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/eci.13259","topics":["Mechanism"],"weight":1,"_version_":1666138495721144322,"score":9.490897,"similar":[{"pmid":32470948,"title":"Why does COVID-19 disproportionately affect older people?","text":["Why does COVID-19 disproportionately affect older people?","The severity and outcome of coronavirus disease 2019 (COVID-19) largely depends on a patient's age. Adults over 65 years of age represent 80% of hospitalizations and have a 23-fold greater risk of death than those 65. In the clinic, COVID-19 patients most commonly present with fever, cough and dyspnea, and from there the disease can progress to acute respiratory distress syndrome, lung consolidation, cytokine release syndrome, endotheliitis, coagulopathy, multiple organ failure and death. Comorbidities such as cardiovascular disease, diabetes and obesity increase the chances of fatal disease, but they alone do not explain why age is an independent risk factor. Here, we present the molecular differences between young, middle-aged and older people that may explain why COVID-19 is a mild illness in some but life-threatening in others. We also discuss several biological age clocks that could be used in conjunction with genetic tests to identify both the mechanisms of the disease and individuals most at risk. Finally, based on these mechanisms, we discuss treatments that could increase the survival of older people, not simply by inhibiting the virus, but by restoring patients' ability to clear the infection and effectively regulate immune responses.","Aging (Albany NY)","Mueller, Amber L","McNamara, Maeve S","Sinclair, David A","32470948"],"abstract":["The severity and outcome of coronavirus disease 2019 (COVID-19) largely depends on a patient's age. Adults over 65 years of age represent 80% of hospitalizations and have a 23-fold greater risk of death than those 65. In the clinic, COVID-19 patients most commonly present with fever, cough and dyspnea, and from there the disease can progress to acute respiratory distress syndrome, lung consolidation, cytokine release syndrome, endotheliitis, coagulopathy, multiple organ failure and death. Comorbidities such as cardiovascular disease, diabetes and obesity increase the chances of fatal disease, but they alone do not explain why age is an independent risk factor. Here, we present the molecular differences between young, middle-aged and older people that may explain why COVID-19 is a mild illness in some but life-threatening in others. We also discuss several biological age clocks that could be used in conjunction with genetic tests to identify both the mechanisms of the disease and individuals most at risk. Finally, based on these mechanisms, we discuss treatments that could increase the survival of older people, not simply by inhibiting the virus, but by restoring patients' ability to clear the infection and effectively regulate immune responses."],"journal":"Aging (Albany NY)","authors":["Mueller, Amber L","McNamara, Maeve S","Sinclair, David A"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470948","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.18632/aging.103344","keywords":["covid-19","aging","cytokine storm","epigenetic clock","immunity"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668167110009815041,"score":139.08267},{"pmid":32437877,"title":"Distinct phenotypes require distinct respiratory management strategies in severe COVID-19.","text":["Distinct phenotypes require distinct respiratory management strategies in severe COVID-19.","Coronavirus disease 2019 (COVID-19) can cause severe respiratory failure requiring mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the clinical presentation of COVID-19 patients are not always like those of typical acute respiratory distress syndrome (ARDS) and can change over time. This manuscript aimed to provide brief guidance for respiratory management of COVID-19 patients before, during, and after mechanical ventilation, based on the recent literature and on our direct experience with this population. We identify that chest CT patterns in COVID-19 may be divided into three main phenotypes: 1) multiple, focal, possibly overperfused ground-glass opacities; 2) inhomogeneously distributed atelectasis; and 3) a patchy, ARDS-like pattern. Each phenotype can benefit from different treatments and ventilator settings. Also, peripheral macro- and microemboli are common, and attention should be paid to the risk of pulmonary embolism. We suggest use of personalized mechanical ventilation strategies based on respiratory mechanics and chest CT patterns. Further research is warranted to confirm our hypothesis.","Respir Physiol Neurobiol","Robba, Chiara","Robba, Chiara","Battaglini, Denise","Ball, Lorenzo","Patroniti, Nicolo'","Loconte, Maurizio","Brunetti, Iole","Vena, Antonio","Giacobbe, Daniele","Bassetti, Matteo","Rocco, Patricia Rieken Macedo","Pelosi, Paolo","32437877"],"abstract":["Coronavirus disease 2019 (COVID-19) can cause severe respiratory failure requiring mechanical ventilation. The abnormalities observed on chest computed tomography (CT) and the clinical presentation of COVID-19 patients are not always like those of typical acute respiratory distress syndrome (ARDS) and can change over time. This manuscript aimed to provide brief guidance for respiratory management of COVID-19 patients before, during, and after mechanical ventilation, based on the recent literature and on our direct experience with this population. We identify that chest CT patterns in COVID-19 may be divided into three main phenotypes: 1) multiple, focal, possibly overperfused ground-glass opacities; 2) inhomogeneously distributed atelectasis; and 3) a patchy, ARDS-like pattern. Each phenotype can benefit from different treatments and ventilator settings. Also, peripheral macro- and microemboli are common, and attention should be paid to the risk of pulmonary embolism. We suggest use of personalized mechanical ventilation strategies based on respiratory mechanics and chest CT patterns. Further research is warranted to confirm our hypothesis."],"journal":"Respir Physiol Neurobiol","authors":["Robba, Chiara","Robba, Chiara","Battaglini, Denise","Ball, Lorenzo","Patroniti, Nicolo'","Loconte, Maurizio","Brunetti, Iole","Vena, Antonio","Giacobbe, Daniele","Bassetti, Matteo","Rocco, Patricia Rieken Macedo","Pelosi, Paolo"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437877","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.resp.2020.103455","keywords":["covid-19","sars-cov-2","mechanical ventilation","non-invasive ventilation","positive end expiratory pressure","prone position"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393748606977,"score":137.92245},{"pmid":32462841,"title":"[Obesity and risk of severe COVID-19].","text":["[Obesity and risk of severe COVID-19].","Obesity represents a higher risk of severe COVID-19 infection, which may lead to the requirement of a mechanical ventilation in intensive care units and premature death. The underlying mechanisms are multiple: alteration of the respiratory performance, presence of comorbidities such as diabetes, hypertension or obstructive sleep apnea, finally inadequate and excessive immunological responses, possibly aggravated by ectopic intrathoracic fat depots. Thus, COVID-19 may challenge the so-called << obesity paradox >> commonly reported by intensivists in patients with acute respiratory distress syndrome. These findings require reinforced preventive and curative measures among obese patients to limit the risk of progression towards an unfavorable outcome in case of COVID-19.","Rev Med Suisse","Scheen, Andre J","32462841"],"abstract":["Obesity represents a higher risk of severe COVID-19 infection, which may lead to the requirement of a mechanical ventilation in intensive care units and premature death. The underlying mechanisms are multiple: alteration of the respiratory performance, presence of comorbidities such as diabetes, hypertension or obstructive sleep apnea, finally inadequate and excessive immunological responses, possibly aggravated by ectopic intrathoracic fat depots. Thus, COVID-19 may challenge the so-called << obesity paradox >> commonly reported by intensivists in patients with acute respiratory distress syndrome. These findings require reinforced preventive and curative measures among obese patients to limit the risk of progression towards an unfavorable outcome in case of COVID-19."],"journal":"Rev Med Suisse","authors":["Scheen, Andre J"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462841","source":"PubMed","week":"202022|May 25 - May 31","locations":["obese"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521509670912,"score":132.99086},{"pmid":32228322,"title":"COVID-19 pandemic, coronaviruses, and diabetes mellitus.","text":["COVID-19 pandemic, coronaviruses, and diabetes mellitus.","The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.","Am J Physiol Endocrinol Metab","Muniyappa, Ranganath","Gubbi, Sriram","32228322"],"abstract":["The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes."],"journal":"Am J Physiol Endocrinol Metab","authors":["Muniyappa, Ranganath","Gubbi, Sriram"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228322","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1152/ajpendo.00124.2020","keywords":["covid-19","coronavirus","diabetes mellitus"],"topics":["Mechanism"],"weight":1,"_version_":1666138492176957440,"score":131.95323},{"pmid":32469255,"title":"SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism.","text":["SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism.","The COVID-19 pandemic, caused by the novel coronavirus, SARS-CoV-2, is threating our health systems and daily lives, and is responsible for causing substantial morbidity and mortality. In particular, aged individuals, and individuals with comorbidities, including obesity, diabetes mellitus, and hypertension, have significantly higher risks of hospitalization and death than normal individuals. The renin-angiotensin system (RAS) plays a pivotal role in the pathogenesis of diabetes mellitus, obesity, and hypertension. Angiotensin converting enzyme 2 (ACE2), belonging to the RAS family, has received much attention during this COVID-19 pandemic, owing to the fact that SARS-CoV-2 uses ACE2 as a receptor for cellular entry. Additionally, the RAS greatly affects energy metabolism in certain pathological conditions, including cardiac failure, diabetes mellitus, and viral infections. This article discusses the potential mechanisms by which SARS-CoV-2 modulates the RAS and energy metabolism in individuals with obesity and diabetes mellitus. The article aims to highlight the appropriate strategies for combating the COVID-19 pandemic in the clinical setting and emphasize on the areas that require further investigation in relation to COVID-19 infections in patients with obesity and diabetes mellitus, from the viewpoint of endocrinology and metabolism.","Am J Physiol Endocrinol Metab","Mori, Jun","Oudit, Gavin Y","Lopaschuk, Gary D","32469255"],"abstract":["The COVID-19 pandemic, caused by the novel coronavirus, SARS-CoV-2, is threating our health systems and daily lives, and is responsible for causing substantial morbidity and mortality. In particular, aged individuals, and individuals with comorbidities, including obesity, diabetes mellitus, and hypertension, have significantly higher risks of hospitalization and death than normal individuals. The renin-angiotensin system (RAS) plays a pivotal role in the pathogenesis of diabetes mellitus, obesity, and hypertension. Angiotensin converting enzyme 2 (ACE2), belonging to the RAS family, has received much attention during this COVID-19 pandemic, owing to the fact that SARS-CoV-2 uses ACE2 as a receptor for cellular entry. Additionally, the RAS greatly affects energy metabolism in certain pathological conditions, including cardiac failure, diabetes mellitus, and viral infections. This article discusses the potential mechanisms by which SARS-CoV-2 modulates the RAS and energy metabolism in individuals with obesity and diabetes mellitus. The article aims to highlight the appropriate strategies for combating the COVID-19 pandemic in the clinical setting and emphasize on the areas that require further investigation in relation to COVID-19 infections in patients with obesity and diabetes mellitus, from the viewpoint of endocrinology and metabolism."],"journal":"Am J Physiol Endocrinol Metab","authors":["Mori, Jun","Oudit, Gavin Y","Lopaschuk, Gary D"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469255","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1152/ajpendo.00219.2020","keywords":["ras","sars-cov-2","energy metabolism","obesity"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668420887258333184,"score":131.76724}]}